PFIZER INC Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $37.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-08-04
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-06-28 was $37.00M.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-03-29 was $76.00M.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-12-31 was -$19.00M, a 111.66% decline year-over-year.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-09-28 was $34.00M.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2025 was -$357.00M, a 328.85% decline from fiscal 2024.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was $156.00M.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2023 was -$33.00M.
- PFIZER INC other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2022 was -$126.00M, a 393.02% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $37.00M 10-Q · filed 2026-08-04 | $112.00M 10-Q · filed 2026-08-04 | $94.00M derived: sum of 3 quarters · filed 2026-08-04 | $128.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $76.00M 10-Q · filed 2026-05-05 | $57.00M derived: sum of 2 quarters · filed 2026-05-05 | $91.00M derived: sum of 3 quarters · filed 2026-05-05 | -$178.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.00M derived: sum of 2 quarters · filed 2026-02-26 | -$254.00M derived: sum of 3 quarters · filed 2026-08-04 | -$357.00M 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | $34.00M 10-Q · filed 2025-11-04 | -$235.00M derived: sum of 2 quarters · filed 2026-08-04 | -$338.00M 10-Q · filed 2025-11-04 | -$174.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | -$269.00M 10-Q · filed 2026-08-04 | -$372.00M 10-Q · filed 2026-08-04 | -$208.00M derived: sum of 3 quarters · filed 2026-08-04 | -$258.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | -$102.00M 10-Q · filed 2026-05-05 | $61.00M derived: sum of 2 quarters · filed 2026-05-05 | $11.00M derived: sum of 3 quarters · filed 2026-05-05 | $29.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $163.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $113.00M derived: sum of 2 quarters · filed 2026-02-26 | $131.00M derived: sum of 3 quarters · filed 2026-02-26 | $156.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | -$50.00M 10-Q · filed 2025-11-04 | -$32.00M derived: sum of 2 quarters · filed 2025-11-04 | -$7.00M 10-Q · filed 2025-11-04 | -$7.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $18.00M 10-Q · filed 2025-08-05 | $42.00M 10-Q · filed 2025-08-05 | $43.00M derived: sum of 3 quarters · filed 2026-02-26 | $15.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $25.00M 10-Q · filed 2025-05-05 | $25.00M derived: sum of 2 quarters · filed 2026-02-26 | -$3.00M derived: sum of 3 quarters · filed 2026-02-26 | $17.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$28.00M derived: sum of 2 quarters · filed 2026-02-26 | -$8.00M derived: sum of 3 quarters · filed 2026-02-26 | -$33.00M 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | -$28.00M 10-Q · filed 2024-11-04 | -$8.00M derived: sum of 2 quarters · filed 2024-11-04 | -$33.00M 10-Q · filed 2024-11-04 | $6.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $20.00M 10-Q · filed 2024-08-05 | -$5.00M 10-Q · filed 2024-08-05 | $34.00M derived: sum of 3 quarters · filed 2025-02-27 | $54.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | -$25.00M 10-Q · filed 2024-05-08 | $14.00M derived: sum of 2 quarters · filed 2025-02-27 | $34.00M derived: sum of 3 quarters · filed 2025-02-27 | -$80.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $59.00M derived: sum of 2 quarters · filed 2025-02-27 | -$55.00M derived: sum of 3 quarters · filed 2025-02-27 | -$126.00M 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | $20.00M 10-Q · filed 2023-11-08 | -$94.00M derived: sum of 2 quarters · filed 2023-11-08 | -$165.00M 10-Q · filed 2023-11-08 | -$93.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | -$114.00M 10-Q · filed 2023-08-09 | -$185.00M 10-Q · filed 2023-08-09 | -$113.00M derived: sum of 3 quarters · filed 2024-02-22 | -$145.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | -$72.00M 10-Q · filed 2023-05-10 | $1.00M derived: sum of 2 quarters · filed 2024-02-22 | -$31.00M derived: sum of 3 quarters · filed 2024-02-22 | -$50.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $41.00M derived: sum of 2 quarters · filed 2024-02-22 | $22.00M derived: sum of 3 quarters · filed 2024-02-22 | $43.00M 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | -$32.00M 10-Q · filed 2022-11-09 | -$51.00M derived: sum of 2 quarters · filed 2022-11-09 | -$30.00M 10-Q · filed 2022-11-09 | $18.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-07-04 | -$19.00M 10-Q · filed 2022-08-10 | $2.00M 10-Q · filed 2022-08-10 | $50.00M derived: sum of 3 quarters · filed 2023-02-23 | $60.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-04-04 | $21.00M 10-Q · filed 2022-05-11 | $69.00M derived: sum of 2 quarters · filed 2023-02-23 | $79.00M derived: sum of 3 quarters · filed 2023-02-23 | $149.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $58.00M derived: sum of 2 quarters · filed 2023-02-23 | $128.00M derived: sum of 3 quarters · filed 2023-02-23 | -$119.00M 10-K · filed 2023-02-23 | -$79.00M 10-K · filed 2021-02-25 | |||
| 2020-09-27 | $10.00M 10-Q · filed 2021-11-12 | $47.00M 10-Q · filed 2020-11-05 | $80.00M derived: sum of 2 quarters · filed 2021-11-12 | -$167.00M 10-Q · filed 2021-11-12 | -$144.00M 10-Q · filed 2020-11-05 | -$3.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $70.00M 10-Q · filed 2021-08-12 | $60.00M 10-Q · filed 2020-08-06 | -$177.00M 10-Q · filed 2021-08-12 | -$192.00M 10-Q · filed 2020-08-06 | -$13.00M derived: sum of 3 quarters · filed 2022-02-24 | $73.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | -$247.00M 10-Q · filed 2021-05-13 | -$252.00M 10-Q · filed 2020-05-07 | -$83.00M derived: sum of 2 quarters · filed 2022-02-24 | $3.00M derived: sum of 3 quarters · filed 2022-02-24 | -$14.00M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $164.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $250.00M derived: sum of 2 quarters · filed 2022-02-24 | $233.00M derived: sum of 3 quarters · filed 2022-02-24 | $260.00M 10-K · filed 2022-02-24 | $254.00M 10-K · filed 2020-02-27 | |||
| 2019-09-29 | $86.00M 10-Q · filed 2020-11-05 | $69.00M derived: sum of 2 quarters · filed 2020-11-05 | $96.00M 10-Q · filed 2020-11-05 | $108.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$17.00M 10-Q · filed 2020-08-06 | $10.00M 10-Q · filed 2020-08-06 | $22.00M derived: sum of 3 quarters · filed 2021-02-25 | $36.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $27.00M 10-Q · filed 2020-05-07 | $39.00M derived: sum of 2 quarters · filed 2021-02-25 | $53.00M derived: sum of 3 quarters · filed 2021-02-25 | $154.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $26.00M derived: sum of 2 quarters · filed 2021-02-25 | $127.00M derived: sum of 3 quarters · filed 2021-02-25 | $94.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $14.00M 10-Q · filed 2019-11-07 | $115.00M derived: sum of 2 quarters · filed 2019-11-07 | $82.00M 10-Q · filed 2019-11-07 | $58.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | $101.00M 10-Q · filed 2019-08-08 | $67.00M 10-Q · filed 2019-08-08 | $44.00M derived: sum of 3 quarters · filed 2020-02-27 | -$18.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | -$34.00M 10-Q · filed 2019-05-09 | -$57.00M derived: sum of 2 quarters · filed 2020-02-27 | -$119.00M derived: sum of 3 quarters · filed 2020-02-27 | -$228.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$85.00M derived: sum of 2 quarters · filed 2020-02-27 | -$194.00M derived: sum of 3 quarters · filed 2020-02-27 | -$215.00M 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | -$62.00M 10-Q · filed 2018-11-08 | -$171.00M derived: sum of 2 quarters · filed 2018-11-08 | -$192.00M 10-Q · filed 2018-11-08 | -$192.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-07-02 | -$109.00M 10-Q · filed 2018-08-09 | -$130.00M 10-Q · filed 2018-08-09 | -$130.00M derived: sum of 3 quarters · filed 2019-02-28 | -$130.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-04-02 | -$21.00M 10-Q · filed 2018-05-10 | -$21.00M derived: sum of 2 quarters · filed 2019-02-28 | -$21.00M derived: sum of 3 quarters · filed 2019-02-28 | -$22.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | -$1.00M derived: sum of 3 quarters · filed 2019-02-28 | -$15.00M 10-K · filed 2019-02-28 | ||||
| 2016-10-02 | $0.00 10-Q · filed 2017-11-09 | -$1.00M derived: sum of 2 quarters · filed 2017-11-09 | -$15.00M 10-Q · filed 2017-11-09 | -$15.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-07-03 | -$1.00M 10-Q · filed 2017-08-10 | -$15.00M 10-Q · filed 2017-08-10 | -$15.00M derived: sum of 3 quarters · filed 2018-02-22 | -$22.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-04-03 | -$14.00M 10-Q · filed 2017-05-11 | -$14.00M derived: sum of 2 quarters · filed 2018-02-22 | -$21.00M derived: sum of 3 quarters · filed 2018-02-22 | -$9.00M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$7.00M derived: sum of 2 quarters · filed 2018-02-22 | $5.00M derived: sum of 3 quarters · filed 2018-02-22 | $90.00M 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | -$7.00M 10-Q · filed 2016-11-10 | $5.00M derived: sum of 2 quarters · filed 2016-11-10 | $90.00M 10-Q · filed 2016-11-10 | $119.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | $12.00M 10-Q · filed 2016-08-11 | $97.00M 10-Q · filed 2016-08-11 | $126.00M derived: sum of 3 quarters · filed 2017-02-23 | $149.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | $85.00M 10-Q · filed 2016-05-12 | $114.00M derived: sum of 2 quarters · filed 2017-02-23 | $137.00M derived: sum of 3 quarters · filed 2017-02-23 | $134.00M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $52.00M derived: sum of 2 quarters · filed 2017-02-23 | $49.00M derived: sum of 3 quarters · filed 2017-02-23 | $42.00M 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | $23.00M 10-Q · filed 2015-11-05 | $20.00M derived: sum of 2 quarters · filed 2015-11-05 | $13.00M 10-Q · filed 2015-11-05 | $36.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | -$3.00M 10-Q · filed 2015-08-06 | -$10.00M 10-Q · filed 2015-08-06 | $13.00M derived: sum of 3 quarters · filed 2016-02-29 | $11.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | -$7.00M 10-Q · filed 2015-05-07 | $16.00M derived: sum of 2 quarters · filed 2016-02-29 | $14.00M derived: sum of 3 quarters · filed 2016-02-29 | $33.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $21.00M derived: sum of 2 quarters · filed 2016-02-29 | $40.00M derived: sum of 3 quarters · filed 2016-02-29 | $111.00M 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | -$2.00M 10-Q · filed 2014-11-06 | $17.00M derived: sum of 2 quarters · filed 2014-11-06 | $88.00M 10-Q · filed 2014-11-06 | $184.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $19.00M 10-Q · filed 2014-08-07 | $90.00M 10-Q · filed 2014-08-07 | $186.00M derived: sum of 3 quarters · filed 2015-02-27 | $163.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $71.00M 10-Q · filed 2014-05-08 | $167.00M derived: sum of 2 quarters · filed 2015-02-27 | $144.00M derived: sum of 3 quarters · filed 2015-02-27 | $114.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $96.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $73.00M derived: sum of 2 quarters · filed 2015-02-27 | $43.00M derived: sum of 3 quarters · filed 2015-02-27 | $110.00M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | -$23.00M 10-Q · filed 2013-11-08 | -$53.00M derived: sum of 2 quarters · filed 2013-11-08 | $14.00M 10-Q · filed 2013-11-08 | $23.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-07-01 | -$30.00M 10-Q · filed 2013-08-09 | $37.00M 10-Q · filed 2013-08-09 | $46.00M derived: sum of 3 quarters · filed 2014-02-28 | -$14.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-04-01 | $67.00M 10-Q · filed 2013-05-10 | $76.00M derived: sum of 2 quarters · filed 2014-02-28 | $16.00M derived: sum of 3 quarters · filed 2014-02-28 | -$34.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$51.00M derived: sum of 2 quarters · filed 2014-02-28 | -$101.00M derived: sum of 3 quarters · filed 2014-02-28 | -$61.00M 10-K · filed 2014-02-28 | ||||
| 2011-10-02 | -$60.00M 10-Q · filed 2012-11-09 | -$110.00M derived: sum of 2 quarters · filed 2012-11-09 | -$70.00M 10-Q · filed 2012-11-09 | |||||
| 2011-07-03 | -$50.00M 10-Q · filed 2012-08-09 | -$10.00M 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | -$165.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |